Skip to content
CTD // Startup

Stipple Bio

Series A

Stipple Bio is a privately held company based in United States, founded in 2021. The latest disclosed round is Series A ($100m), dated Mar 31, 2026. Institutional investors on record include Andreessen Horowitz, Google Ventures.

United States · EST 2021

What is Stipple Bio?

Stipple Bio is a privately held company based in United States, founded in 2021. The latest disclosed round is Series A ($100m), dated Mar 31, 2026. Institutional investors on record include Andreessen Horowitz, Google Ventures. Provider of a platform that utilizes epitope-level resolution to unlock cellular profiling and target discovery. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.

Which funds backed Stipple Bio?

Who invested in Stipple Bio?

Funds on the dated round table. Open a name to read the fund card.

InvestorRoundAmountDate
Andreessen HorowitzSeries A$100mMar 31, 2026
Google VenturesSeries A$100mMar 31, 2026

What do founders ask about Stipple Bio?

What is Stipple Bio?

Stipple Bio is a privately held company based in United States, founded in 2021. The latest disclosed round is Series A ($100m), dated Mar 31, 2026. Institutional investors on record include Andreessen Horowitz, Google Ventures. Provider of a platform that utilizes epitope-level resolution to unlock cellular profiling and target discovery. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.

What was Stipple Bio's last funding round?

Stipple Bio's latest disclosed round is Series A at $100m (Mar 31, 2026).

Who invested in Stipple Bio?

Stipple Bio has 2 institutional investors on this page, including Andreessen Horowitz, Google Ventures.

How does CrackTheDeck cover Stipple Bio?

This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.

How is this page compiled?

Round, amount, and investor names on the Stipple Bio card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.

LiveUpdated Aug 2026Most active VC funds